CyberArk Software Shares Crash As Company Posts Disappointing Guidance Numbers
CyberArk Software Ltd. (CYBR), a global software-based IT security solutions yesterday reported their preliminary second quarter 2017 financial results. CyberArk reported that they expect second quarter revenues to be in between $57 to $57.5 million which is down from previous guidance of $61 to $62 million. CyberArk Software Ltd. CEO’s Comments “We are disappointed that our […]
Banks Down, Market Wants Upward Follow Through On Darvas Breakout
Out of the Darvas Box – just barely though Okay, so we have been here before. This almost-two month long box that the S&P 500 has been trading in has been broken for only the second time, yesterday. The last time it broke was on June 19th, and the following day resulted in a huge […]
SPX Cycles, Fed Funds And Gold
This “amateur cyclist’s” chart (I am anything but a cycles analyst) of the S&P 500 shows that the 12 month marker (C12) meant exactly nothing as the market remained firmly on trend, after brief pokes down in April and May. We noted that C12 was a lesser indicator than the 30 month cycle, which has coincided with some pretty significant […]
Better Dividend Aristocrat: Sherwin-Williams Or PPG?
PPG Industries (PPG) is a Dividend Aristocrat. It has increased its dividend for 44 years in a row, which is certainly an impressive feat. That said, there may be a better Dividend Aristocrat to buy, and it happens to be one of PPG’s biggest competitors. Sherwin-Williams (SHW) has 38 consecutive years of dividend increases under […]
Biotech Digest – FMI Inks New Deal, SGMI Gets Fast Track Designation, ANTM Files A Suit
Top Pick of the Day: FMI Foundation Medicine Inc. (Nasdaq: FMI) announced inking a new deal with Kura Oncology for supporting enrollment in its its Phase 2 clinical trial evaluating farnesylation inhibitor tipifarnib in patients with treatment-resistant HRAS-mutant squamous cell carcinoma of the head and neck (SCCHN). Under the terms of the collaboration, Foundation Medicine’s […]
Dollar, Yields Dive After CPI Disappoints
Ok, well the biggest econ print of the week is in and it’s a miss. You can read the full breakdown here, but suffice to say the CPI disappointment is another blow to the Fed’s “transitory” narrative and if this trend doesn’t turn around soon, they’ll need to come right out and admit that they are […]
Consumer Price Index: Headline & Core Below 2% Again
The Bureau of Labor Statistics released the June Consumer Price Index data this morning. The year-over-year non-seasonally adjusted Headline CPI came in at 1.63%, down from 1.87% the previous month. Year-over-year Core CPI (ex Food and Energy) came in at 1.70%, down from the previous month’s 1.73%. Here is the introduction from the BLS summary, […]
JPMorgan (JPM) Q2 Earnings Beat On Loan Growth, Higher Rates
Rising interest rates and loan growth drove JPMorgan Chase & Co.’s (JPM – Free Report) second-quarter 2017 earnings of $1.82 per share, which easily surpassed the Zacks Consensus Estimate of $1.57. Also, the figure reflects a 17% rise from the year-ago period. Notably, the results included a legal benefit of $406 million. Solid loan growth and higher interest […]
Inflation Siesta
The latest economic data came out this morning, and it indicates that, in spite of the Fed’s best efforts, inflation just is not kicking in. CPI fell for the fourth month in a row, and the US dollar has continued doing what it’s been doing the entirety of 2017, which is sink. In turn, precious […]
Should Platinum Be More Expensive Than Gold?
Platinum is one of the rarest elements in the world, much rarer than gold. This is why historically the white metal has been more valuable – just think of platinum credit cards which offer greater privileges and prestige than the gold ones. However, the ‘little silver’ has recently been traded at a discount to gold, as one […]
